Member Highlight: The END Fund
The END Fund is the only private philanthropic initiative solely dedicated to ending the five most common neglected tropical diseases (NTDs), which affect more than 1.5 billion people globally. It efficiently puts private capital to work, advocating for NTD programs that are innovative, integrated, and cost-effective. It facilitates strong partnerships with the private sector and aims to support national disease control programs in over 29 countries.
Since its founding in 2012, with dedicated partners, the END Fund has provided over 500 million donated treatments worth almost $933 million, over 11,400 surgeries for people suffering from the effects of the advanced stages of elephantiasis and trachoma, and trained more than 1.1 million people in NTD control and elimination efforts. See the 2017 Annual Report for more information.